The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
miR-34: from bench to bedside
Open accessAbstract
// Massimiliano Agostini 1 and Richard A. Knight 1 1 Medical Research Council, Toxicology Unit, Leicester University, Leicester, UK. Correspondence: Massimiliano Agostini, email: // Keywords : microRNA, miR-34 family, cancer, therapy Received : February 16, 2014 Accepted : March 15, 2014 Published : March 15, 2014 Abstract The mir-34 family was originally cloned and characterized in 2007 as a p53 target gene. Almost immediately it became clear that its major role is as a master regulator of tumor suppression. Indeed, when overexpressed, it directly and indirectly represses several oncogenes, resulting in an increase of cancer cell death (including cancer stem cells), and in an inhibition of metastasis. Moreover, its expression is deregulated in several human cancers. In 2013, a miR-34 mimic has become the first microRNA to reach phase 1 clinical trials. Here we review the miR-34 family and their role in tumor biology, and discuss the potential therapeutic applications of miR-34a mimic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans
Lau, N. C., Lim, L. P., Weinstein, E. G., & Bartel, D. P. (2001) · Science · doi:10.1126/science.1065062 · Cited by 3,345
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005) · Science · doi:10.1126/science.1113329 · Cited by 2,521
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Garzon, R., Calin, G. A., & Croce, C. M. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.59.053006.104707 · Cited by 1,770
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation
Ørom, U. A., Nielsen, F. C., & Lund, A. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.001 · Cited by 1,384
Small non-coding RNAs in animal development
Stefani, G., & Slack, F. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2347 · Cited by 1,368
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236 · cited 1×
“They are also involved in pathological conditions such as cancer [2-7] and neurodegeneration [8-11].”
BackgroundAutophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., Zhang, Q., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.350 · Cited by 1,204
Cancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171
p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,123
A microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078
Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 990
Targeting cellular metabolism to improve cancer therapeutics
Zhao, Y., Butler, E. B., & Tan, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.60 · Cited by 989
Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., & Hermeking, H. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4436 · Cited by 923
Tazawa, H., Tsuchiya, N., Izumiya, M., & Nakagama, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707351104 · Cited by 903
MicroRNA-34a regulates cardiac ageing and function.
Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., et al. (2013) · Nature · doi:10.1038/nature11919 · Cited by 821
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
Welch, C., Chen, Y., & Stallings, R. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210293 · Cited by 805
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Körner, H., Knyazev, P., Diebold, J., & Hermeking, H. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6533 · Cited by 784
miR-34 – a microRNA replacement therapy is headed to the clinic
Bader, A. G. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00120 · Cited by 728
miR-221 overexpression contributes to liver tumorigenesis
Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., Mazzaferro, V., Lowe, S. W., Croce, C. M., & Dejean, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907904107 · Cited by 699
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Patrawala, L., Brown, D., & Bader, A. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0655 · Cited by 677
MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
Li, Y., Guessous, F., Zhang, Y., DiPierro, C., Kefas, B., Johnson, E., Marcinkiewicz, L., Jiang, J., Yang, Y., Schmittgen, T. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0529 · Cited by 614
Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., & Tokino, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0325 · Cited by 600
Eiring, A. M., Harb, J. G., Neviani, P., Garton, C., Oaks, J. J., Spizzo, R., Liu, S., Schwind, S., Santhanam, R., Hickey, C. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.007 · Cited by 560
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 515
Downregulation of CCND1 and CDK6 by miR‐34a induces cell cycle arrest
Sun, F., Fu, H., Liu, Q., Tie, Y., Zhu, J., Xing, R., Sun, Z., & Zheng, X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.057 · Cited by 514
MiR-34, SIRT1, and p53: The feedback loop
Yamakuchi, M., & Lowenstein, C. J. (2009) · Cell Cycle · doi:10.4161/cc.8.5.7753 · Cited by 468
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition
Kim, N. H., Kim, H. S., Li, X.-Y., Lee, I., Choi, H.-S., Kang, S. E., Cha, S. Y., Ryu, J. K., Yoon, D., Fearon, E. R., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201103097 · Cited by 432
TAp73 knockout shows genomic instability with infertility and tumor suppressor functions
Tomasini, R., Tsuchihara, K., Wilhelm, M., Fujitani, M., Rufini, A., Cheung, C. C., Khan, F., Itie-Youten, A., Wakeham, A., Tsao, M.-S., et al. (2008) · Genes & Development · doi:10.1101/gad.1695308 · Cited by 429
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
Ji, Q., Hao, X., Meng, Y., Zhang, M., DeSano, J., Fan, D., & Xu, L. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-266 · Cited by 394
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Choi, Y. J., Lin, C.-P., Ho, J. J., He, X., Okada, N., Bu, P., Zhong, Y., Kim, S. Y., Bennett, M. J., Chen, C., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2366 · Cited by 382
A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
Bu, P., Chen, K.-Y., Chen, J. H., Wang, L., Walters, J., Shin, Y. J., Goerger, J. P., Sun, J., Witherspoon, M., Rakhilin, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.002 · Cited by 357
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC
Christoffersen, N. R., Shalgi, R., Frankel, L. B., Leucci, E., Lees, M., Klausen, M., Pilpel, Y., Nielsen, F. C., Oren, M., & Lund, A. H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.109 · Cited by 352
Chemokines in tumor progression and metastasis
Sarvaiya, P. J., Guo, D., Ulasov, I., Gabikian, P., & Lesniak, M. S. (2013) · Oncotarget · doi:10.18632/oncotarget.1426 · Cited by 348
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Fujita, Y., Kojima, K., Hamada, N., Ohhashi, R., Akao, Y., Nozawa, Y., Deguchi, T., & Ito, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.086 · Cited by 331
Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Mediated Gene Regulation
Meijer, H. A., Kong, Y. W., Lu, W. T., Wilczynska, A., Spriggs, R. V., Robinson, S. W., Godfrey, J. D., Willis, A. E., & Bushell, M. (2013) · Science · doi:10.1126/science.1231197 · Cited by 326
A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene
Cole, K. A., Attiyeh, E. F., Mosse, Y. P., Laquaglia, M. J., Diskin, S. J., Brodeur, G. M., & Maris, J. M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2102 · Cited by 316
Vogt, M., Munding, J., Grüner, M., Liffers, S.-T., Verdoodt, B., Hauk, J., Steinstraesser, L., Tannapfel, A., & Hermeking, H. (2011) · Virchows Archiv · doi:10.1007/s00428-010-1030-5 · Cited by 309
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
Corney, D. C., Hwang, C.-I., Matoso, A., Vogt, M., Flesken-Nikitin, A., Godwin, A. K., Kamat, A. A., Sood, A. K., Ellenson, L. H., Hermeking, H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2642 · Cited by 308
p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
Kim, N. H., Kim, H. S., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Kang, S. E., Cha, S. Y., Ryu, J. K., Na, J. M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001744 · Cited by 308
Pramanik, D., Campbell, N. R., Karikari, C., Chivukula, R., Kent, O. A., Mendell, J. T., & Maitra, A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0152 · Cited by 296
The MYCN oncogene is a direct target of miR-34a
Wei, J. S., Song, Y. K., Durinck, S., Chen, Q.-R., Cheuk, A. T. C., Tsang, P., Zhang, Q., Thiele, C. J., Slack, A., Shohet, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.154 · Cited by 296
Tucci, P., Agostini, M., Grespi, F., Markert, E. K., Terrinoni, A., Vousden, K. H., Muller, P. A. J., Dötsch, V., Kehrloesser, S., Sayan, B. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110977109 · Cited by 286
Self-citationA threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.
Kracikova, M., Akiri, G., George, A., Sachidanandam, R., & Aaronson, S. A. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.155 · Cited by 261
Nalls, D., Tang, S.-N., Rodova, M., Srivastava, R. K., & Shankar, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024099 · Cited by 256
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
Mudduluru, G., Ceppi, P., Kumarswamy, R., Scagliotti, G. V., Papotti, M., & Allgayer, H. (2011) · Oncogene · doi:10.1038/onc.2011.13 · Cited by 252
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1
Yang, S., Li, Y., Gao, J., Zhang, T., Li, S., Luo, A., Chen, H., Ding, F., Wang, X., & Liu, Z. (2013) · Oncogene · doi:10.1038/onc.2012.432 · Cited by 228
Kong, Y. W., Cannell, I. G., de Moor, C. H., Hill, K., Garside, P. G., Hamilton, T. L., Meijer, H. A., Dobbyn, H. C., Stoneley, M., Spriggs, K. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800650105 · Cited by 206
Isoform-specific p73 knockout mice reveal a novel role for ΔNp73 in the DNA damage response pathway
Wilhelm, M. T., Rufini, A., Wetzel, M. K., Tsuchihara, K., Inoue, S., Tomasini, R., Itie-Youten, A., Wakeham, A., Arsenian-Henriksson, M., Melino, G., et al. (2010) · Genes & Development · doi:10.1101/gad.1873910 · Cited by 203
Molecular basis of IIq23 rearrangements in hematopoietic malignant proliferations
Bernard, O. A., & Berger, R. (1995) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870130202 · Cited by 202
Kaller, M., Liffers, S.-T., Oeljeklaus, S., Kuhlmann, K., Röh, S., Hoffmann, R., Warscheid, B., & Hermeking, H. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010462 · Cited by 201
Leucci, E., Cocco, M., Onnis, A., De Falco, G., van Cleef, P., Bellan, C., van Rijk, A., Nyagol, J., Byakika, B., Lazzi, S., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2410 · Cited by 198
Intact p53-Dependent Responses in miR-34–Deficient Mice
Concepcion, C. P., Han, Y.-C., Mu, P., Bonetti, C., Yao, E., D'Andrea, A., Vidigal, J. A., Maughan, W. P., Ogrodowski, P., & Ventura, A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002797 · Cited by 197
The Quest for the 1p36 Tumor Suppressor
Bagchi, A., & Mills, A. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2095 · Cited by 196
miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
Karaayvaz, M., Zhai, H., & Ju, J. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.193 · Cited by 191
Bier, A., Giladi, N., Kronfeld, N., Lee, H. K., Cazacu, S., Finniss, S., Xiang, C., Poisson, L., deCarvalho, A. C., Slavin, S., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.928 · Cited by 190
microRNA-34a regulates neurite outgrowth, spinal morphology, and function
Agostini, M., Tucci, P., Steinert, J. R., Shalom-Feuerstein, R., Rouleau, M., Aberdam, D., Forsythe, I. D., Young, K. W., Ventura, A., Concepcion, C. P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112063108 · Cited by 185
Self-citationFareh, M., Turchi, L., Virolle, V, Debruyne, D., Almairac, F., de-la-Forest Divonne, S., Paquis, P., Preynat-Seauve, O., Krause, K.-H., Chneiweiss, H., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.89 · Cited by 180
de Antonellis, P., Medaglia, C., Cusanelli, E., Andolfo, I., Liguori, L., De Vita, G., Carotenuto, M., Bello, A., Formiggini, F., Galeone, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024584 · Cited by 171
Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets
Agostini, M., Tucci, P., Killick, R., Candi, E., Sayan, B. S., Rivetti di val Cervo, P., Nicotera, P., McKeon, F., Knight, R. A., Mak, T. W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112061109 · Cited by 171
Self-citationAudrito, V., Vaisitti, T., Rossi, D., Gottardi, D., D'Arena, G., Laurenti, L., Gaidano, G., Malavasi, F., & Deaglio, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4452 · Cited by 168
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
Ahn, Y., Gibbons, D. L., Chakravarti, D., Creighton, C. J., Rizvi, Z. H., Adams, H. P., Pertsemlidis, A., Gregory, P. A., Wright, J. A., Goodall, G. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63608 · Cited by 162
MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9
Yang, J., Chen, D., He, Y., Meléndez, A., Feng, Z., Hong, Q., Bai, X., Li, Q., Cai, G., Wang, J., et al. (2011) · AGE · doi:10.1007/s11357-011-9324-3 · Cited by 161
Parisi, C., Arisi, I., D’Ambrosi, N., Storti, A. E., Brandi, R., D’Onofrio, M., & Volonté, C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.491 · Cited by 155
MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1
Wu, J., Wu, G., Lv, L., Ren, Y.-F., Zhang, X., Xue, Y.-F., Li, G., Lu, X., Sun, Z. S., & Tang, K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr304 · Cited by 145
Siemens, H., Neumann, J. H. L., Jackstadt, R., Mansmann, U., Horst, D. A., Kirchner, T., & Hermeking, H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1703 · Cited by 144
A miR‐34a‐SIRT6 axis in the squamous cell differentiation network
Lefort, K., Brooks, Y., Ostano, P., Cario, M., Calpini, V., Guinea‐Viniegra, J., Albinger‐Hegyi, A., Hoetzenecker, W., Kolfschoten, I., Wagner, E. F., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.156 · Cited by 138
Lin, J., Teo, S. H., Lam, D. H., Jeyaseelan, K., & Wang, S. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.134 · Cited by 136
miR-34b Targets Cyclic AMP–Responsive Element Binding Protein in Acute Myeloid Leukemia
Pigazzi, M., Manara, E., Baron, E., & Basso, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3404 · Cited by 131
Silber, J., Skanderup, A. J., Ozawa, T., Harinath, G., Pedraza, A. M., Sander, C., Holland, E. C., & Huse, J. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033844 · Cited by 130
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
Yin, D., Ogawa, S., Kawamata, N., Leiter, A., Ham, M., Li, D., Doan, N., SAID, J. W., Black, K. L., & Koeffler, H. P. (2012) · Oncogene · doi:10.1038/onc.2012.132 · Cited by 125
Kinoshita, T., Hanazawa, T., Nohata, N., Kikkawa, N., Enokida, H., Yoshino, H., Yamasaki, T., Hidaka, H., Nakagawa, M., Okamoto, Y., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.709 · Cited by 125
BioProfiling.de: analytical web portal for high-throughput cell biology
Antonov, A. V. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr372 · Cited by 118
p53 regulates glucose metabolism by miR-34a
Kim, H.-R., Roe, J., Lee, J., Cho, E., & Youn, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.043 · Cited by 116
Kim, N. H., Cha, Y. H., Kang, S. E., Lee, Y. M., Lee, I., Cha, S. Y., Ryu, J. K., Na, J. M., Park, C., Yoon, H., et al. (2013) · Cell Cycle · doi:10.4161/cc.24739 · Cited by 109
1p36 Tumor Suppression—A Matter of Dosage?
Henrich, K., Schwab, M., & Westermann, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2230 · Cited by 104
MicroRNA-34a upregulation during seizure-induced neuronal death
Sano, T., Reynolds, J. R., Jimenez-Mateos, E. M., Matsushima, S., Taki, W., & Henshall, D. C. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.23 · Cited by 103
Shen, Z.-S., Zhan, G., Ye, D., Ren, Y., Cheng, L.-X., Wu, Z.-H., & Guo, J. (2012) · Medical Oncology · doi:10.1007/s12032-011-0156-x · Cited by 99
Identification of miR-30d as a novel prognostic maker of prostate cancer
Kobayashi, N., Uemura, H., Nagahama, K., Okudela, K., Furuya, M., Ino, Y., Ito, Y., Hirano, H., Inayama, Y., Aoki, I., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.696 · Cited by 95
Lezina, L., Purmessur, N. S., Antonov, A. V., Ivanova, T., Karpova, E., Kumar, K., Ivan, M., Aksenova, V., Tentler, D., Garabadgiu, A. V., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.483 · Cited by 91
Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a
Chen, Q., Yu, L., Tsang, P., Wei, J. S., Song, Y., Cheuk, A., Chung, J., Hewitt, S. M., Veenstra, T. D., & Khan, J. I. (2010) · Journal of Proteome Research · doi:10.1021/pr1006697 · Cited by 89
p73: A Multifunctional Protein in Neurobiology
Killick, R., Niklison-Chirou, M. V., Tomasini, R., Bano, D., Rufini, A., Grespi, F., Velletri, T., Tucci, P., Sayan, B. S., Conforti, F., et al. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8172-6 · Cited by 85
Self-citationExpression level of human miR-34a correlates with glioma grade and prognosis
Gao, H., Zhao, H., & Xiang, W. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1119-1 · Cited by 84
Controlled delivery of antisense oligonucleotides: a brief review of current strategies
Zhao, X., Pan, F., Holt, C. M., Lewis, A. L., & Lu, J. R. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902992894 · Cited by 82
MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme
Li, W., Ma, M., Dong, L., Wang, F., Chen, L., & Li, X. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.6.16300 · Cited by 77
Antonov, A. V., Knight, R. A., Melino, G., Barlev, N. A., & Tsvetkov, P. O. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.137 · Cited by 66
Self-citationMicroRNAs tune cerebral cortical neurogenesis
Volvert, M.-L., Rogister, F., Moonen, G., Malgrange, B., & Nguyen, L. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.96 · Cited by 66
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia
Visone, R., Veronese, A., Balatti, V., & Croce, C. M. (2012) · Oncotarget · doi:10.18632/oncotarget.448 · Cited by 47
Cancer Metabolism: New Validated Targets for Drug Discovery
Sotgia, F., Martinez‐Outschoorn, U., & Lisanti, M. P. (2013) · Oncotarget · doi:10.18632/oncotarget.1182 · Cited by 44
Brabletz, T. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18900 · Cited by 44
Liu, J., Nau, M. M., Zucman‐Rossi, J., Powell, J. I., Allegra, C. J., & Wright, J. J. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199703)18:3<175::aid-gcc4>3.3.co;2-r · Cited by 43
Ghawanmeh, T., Thunberg, U., Castro, J., Murray, F., & Laytragoon‐Lewin, N. (2011) · Oncology · doi:10.1159/000334237 · Cited by 42
Liu, H., Zhang, W., Jia, Y., Yu, Q., Grau, G. E., Peng, L., Ran, Y., Yang, Z., Deng, H., & Lou, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.340 · Cited by 41
A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH
Kim, H.-R., Roe, J., Lee, J., Hwang, I., Cho, E., & Youn, H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.077 · Cited by 41
New roles for “old” microRNAs in nervous system function and disease
Hartl, M., & Kadow, I. C. G. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00051 · Cited by 18
MicroRNAs as regulators of tumor-associated stromal cells
Ell, B. J., & Kang, Y. (2013) · Oncotarget · doi:10.18632/oncotarget.1625 · Cited by 6
p73 – constitutively open for business
Seeliger, M. A., & Moll, U. M. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.56 · Cited by 4
Cited by
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,032
Zinc-finger proteins in health and disease
Cassandri, M., Smirnov, A., Novelli, F., Pitolli, C., Agostini, M., Malewicz, M., Melino, G., & Raschellà, G. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.71 · Cited by 852
Self-citationmiR-122 – A key factor and therapeutic target in liver disease
Bandiera, S., Pfeffer, S., Baumert, T. F., & Zeisel, M. B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.004 · Cited by 629
RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?
Bobbin, M. L., & Rossi, J. J. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103633 · Cited by 353
Alternative mechanisms of miR-34a regulation in cancer
Slabáková, E., Culig, Z., Remšík, J., & Souček, K. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.495 · Cited by 264
Metadata
- Authors
- Agostini, M., & Knight, R. A.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-02-28
- Volume
- 5
- Issue
- 4
- Pages
- 872-881
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2152035403
- Cited by
- 254
- References
- 102
- FWCI
- 11.37
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.